FDA pharmacologic class
Interleukin-17A Antagonist
2 medicines are in FDA's class of interleukin-17a antagonists: ixekizumab (Taltz) and secukinumab (Cosentyx). 0 of the 2 are listed from generic labelers (FDA NDC Directory, October 8, 2026). The lowest pharmacy cost is cosentyx sensoready 300 mg dose/2 pens (150 mg/pen) at $3,946.35 per mL (NADAC).
Which medicines are interleukin-17a antagonist?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Ixekizumab | Taltz | none listed | $7,370.72 per mL 80 mg/mL autoinjector | No | No current entry | 0 |
| Secukinumab | Cosentyx | none listed | $3,946.35 per mL 300 mg dose/2 pens (150 mg/pen) | No | No current entry | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price